Anticholinergic and benzodiazepine medication use and risk of incident dementia: a UK cohort study.
Carlota M GrossiKathryn RichardsonChris FoxIan MaidmentNicholas SteelYoon K LokeAntony ArthurPhyo Kyaw MyintNoll CampbellMalaz BoustaniLouise RobinsonCarol BrayneFiona E MatthewsGeorge M SavvaPublished in: BMC geriatrics (2019)
Neither benzodiazepines nor ACB12 medications were associated with dementia. Recurrent use of ACB3 anticholinergics was associated with dementia, particularly in those with good baseline cognitive function. The long-term prescribing of anticholinergics should be avoided in older people.